Shalby Limited Inaugurates Advanced Oncology Department at Surat Hospital
Shalby Limited has officially inaugurated its new oncology department at Shalby Multi-Specialty Hospital, Surat, as disclosed under SEBI regulations. The facility features advanced radiotherapy technology and is supported by experienced medical, radiation, and surgical oncologists to provide comprehensive cancer treatment under one roof for the South Gujarat region.

*this image is generated using AI for illustrative purposes only.
Shalby Limited has officially inaugurated its new oncology department at Shalby Multi-Specialty Hospital, Surat, as disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015. The new department features advanced radiotherapy capabilities designed to provide comprehensive cancer treatment under one roof.
Advanced Cancer Treatment Facility
The newly inaugurated oncology department at Shalby Hospital, Surat, is equipped with state-of-the-art radiotherapy technology. This development enables the hospital to offer integrated cancer care services, allowing patients to receive complete treatment at a single location.
| Facility Details: | Information |
|---|---|
| Location: | Shalby Multi-Specialty Hospital, Surat |
| Department: | Oncology with Advanced Radiotherapy |
| Service Model: | Comprehensive cancer treatment |
| Technology: | Advanced radiotherapy equipment |
| Target Region: | South Gujarat region |
Expert Medical Team and Comprehensive Care
The department is supported by an experienced team of medical, radiation, and surgical oncologists, enabling patients to receive specialized diagnosis and treatment at a single location. Through advanced technology, expert medical teams, and a patient-centric approach, the hospital aims to ensure timely diagnosis and effective treatment for patients in the South Gujarat region.
Regulatory Disclosure and Strategic Expansion
The company made this announcement through a formal disclosure to NSE and BSE under Regulation 30 of SEBI (LODR) Regulations, 2015, highlighting the significance of this development. This launch aligns with Shalby Limited's strategy to enhance its healthcare infrastructure and provide advanced medical services across its network.
| Regulatory Details: | Information |
|---|---|
| Filing Date: | March 9, 2026 |
| NSE Scrip Code: | SHALBY |
| BSE Scrip Code: | 540797 |
| Regulation: | SEBI (LODR) Regulations, 2015 |
The addition of oncology services with radiotherapy capabilities strengthens the company's position in specialized healthcare delivery and demonstrates its commitment to providing accessible cancer care in the region.
Historical Stock Returns for Shalby
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.13% | -4.22% | -8.13% | -36.41% | -30.08% | +37.42% |
































